Table 1.
Sociodemographic and disease characteristics of the study population.
| Variable | Number | Percentage (%) |
|---|---|---|
| Gender | ||
| Male | 76 | 46.1 |
| Female | 89 | 53.9 |
| Ethnicity | ||
| Sinhalese | 106 | 64.2 |
| Muslim | 43 | 26.1 |
| Tamil | 15 | 9.1 |
| Other | 1 | 0.6 |
| Level of education | ||
| No formal education | 7 | 4.2 |
| Grades 1–5 | 11 | 6.7 |
| Grades 6–10 | 40 | 24.2 |
| Up to GCE O/L | 77 | 46.7 |
| Up to GCE A/L | 19 | 11.5 |
| Higher education | 11 | 6.7 |
| Monthly income | ||
| <LKR 10,000 (~US$ 65) | 41 | 24.8 |
| LKR 10,000–50,000 (~US$ 65–325) | 119 | 72.1 |
| >LKR 50,000 (~US$ 325) | 5 | 3.0 |
| Occupation | ||
| Retired/unemployed | 96 | 58.2 |
| Manual worker | 27 | 16.4 |
| Managerial worker | 16 | 9.7 |
| Clerical worker | 6 | 3.6 |
| Other | 20 | 12.1 |
| Comorbid diseases | ||
| Hypertension | 95 | 57.6 |
| Hyperlipidaemia | 64 | 38.8 |
| Ischaemic heart disease | 47 | 28.5 |
| Bronchial asthma | 15 | 9.1 |
| Number of antidiabetic medications | ||
| One | 58 | 35.2 |
| Two | 91 | 55.2 |
| Three | 16 | 9.7 |
| Type of antidiabetic medication | ||
| Metformin | 135 | 81.8 |
| Gliclazide | 63 | 38.2 |
| Insulin | 56 | 33.9 |
| Sitagliptin | 9 | 5.4 |
| Glibenclamide | 7 | 4.2 |
| Poor glycaemic control (HbA1c ≥ 8.5%) | 69 | 41.8 |
| Medication adherence (BMQ) | ||
| Regimen screen (no positive response) | 65 | 39.4 |
| Belief screen (no positive response) | 125 | 75.8 |
| Recall screen (no positive response) | 31 | 18.8 |
| Overall adherence | ||
| Adherent (no positive response) | 18 | 10.9 |
| Probable adherence (positive response in 1 screen) | 47 | 28.5 |
| Probable low adherence (positive response in 2 screens) | 46 | 16.4 |
| Low adherence (positive response in 3 screens) | 54 | 32.8 |